Viewing Study NCT02015169


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-03 @ 8:39 PM
Study NCT ID: NCT02015169
Status: COMPLETED
Last Update Posted: 2018-01-17
First Post: 2013-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module